Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
13
13 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- folinic acidPhase 34 trials
Astellas · Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
- pudexacianinium chlorideASP5354Phase 32 trials
Astellas · Intraoperative Ureter Visualization, Abdominolpelvic Surgery
- RoxadustatFG-4592, ASP1517Phase 32 trials
Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes
- SetidegrasibASP3082Phase 32 trials
Astellas · Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
- ASP2138Phase 31 trial
Astellas · Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
- XNW27011ASP546CPhase 22 trials
Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
- ASP2246Phase 21 trial
Astellas · Chronic Ischemic Stroke
- ASP2767Phase 21 trial
Astellas · Glaucoma
- ASP2957MyoAAV3.8 engineered capsid - myosin heavy chain kinase 7 - human myotubularin, MyoAAV3.8-MHCK7-hMTM1Phase 21 trial
Astellas · X-linked Myotubular Myopathy
- ASP2998Phase 21 trial
Astellas · Locally Advanced or Metastatic Malignant Solid Tumors
- ASP388BPhase 21 trial
Astellas · Locally Advanced or Metastatic Solid Tumors
- ASP5541PRL-02Phase 21 trial
Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
- Tacrolimus prolonged releasePhase 21 trial
Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.